Back to companies

Oncopeptides AB: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Oncopeptides AB’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Oncopeptides AB's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Per Wold-Olsen

Chairman Executive Board Since: 2018 Age: 78

Sofia Heigis

Chief Executive Officer Senior Management Since: 2023 Age: 45

Henrik Bergentoft

Chief Financial Officer Senior Management Since: 2023 Age: 51

Eva Nordstrom

Chief Operating Officer Senior Management Since: 2012

David Augustsson

Director - IR and Communications Senior Management Since: 2023 Age: 41
Gain a 360-degree view of Oncopeptides AB and make more informed decisions for your business Gain a 360-degree view of Oncopeptides AB and make more informed decisions for your business Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer